Mkts

TransMedics Group, Inc.

NASDAQ: TMDX
$92.01+1.06 (+1.17%)
As of Nov 11, 4:00 PM ET

Key statistics

Day range
90.0093.46
52-week range
60.10156.00
Today
Open90.95
Previous close92.01
Volume—
Valuation
Market cap3.23B
P/E ratio21.28×
EPS (TTM)3.73
Income & risk
Dividend / yield—
Beta2.17
Avg volume911.3K
Discussion

TMDX News

Stories mentioning TMDX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue173,933160,764143,823157,370143,537121,624108,761114,305
Cost of Goods Sold72,77267,35059,24860,78155,30949,61147,91645,044
Gross Profit101,16193,41484,57596,58988,22872,01360,84569,261
Operating Expenses
Research & Development24,87920,70115,26015,93417,16016,46414,26613,858
Sales General & Admin62,98551,44046,01544,08843,62546,90542,65642,895
Total Operating Expenses87,86472,14161,27560,02260,78563,36956,92256,753
Operating Income (Loss)13,29721,27323,30036,56727,4438,6443,92312,508
Interest Income
Interest Expense3,623
Other Expense
Pretax Income8,48521,63323,03136,18226,6766,9894,24512,153
Tax Provision1,170(83,750)(1,288)1,275994.00132.0029.00(41.00)
Net Income (Loss)7,315105,38324,31934,90725,6826,8574,21612,194
Earnings Per Share (Basic)0.213.100.711.030.760.210.130.37
Earnings Per Share (Diluted)0.202.600.660.920.700.190.120.35
Weighted Average Shares Outstanding (Basic)34,38433,99334,11233,91333,72233,23033,44133,120
Weighted Average Shares Outstanding (Diluted)36,19440,54140,74840,55939,91435,21735,68435,288

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TMDX

TransMedics Group, Inc. (NASDAQ: TMDX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TMDX. It last traded at $92.01 (Nov 11, 2026, 4:00 PM ET), up 1.2% on the day. That gives TransMedics a market capitalisation of $3.2B and a price-to-earnings ratio of 21.3.

Over the past 52 weeks TMDX has traded between $60.10 and $156.00.

Revenue for the quarter ended Mar 31, 2026 was $173.9M; net income $7.3M. Revenue was up 21.2% from $143.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$173.9M$7.3M4.2%
Dec 31, 2025$160.8M$105.4M65.6%
Sep 30, 2025$143.8M$24.3M16.9%
Jun 30, 2025$157.4M$34.9M22.2%

From TransMedics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…